1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Antibody Development and Production Services by Type
  • 1.3.1 Overview: Global Antibody Development and Production Services Market Size by Type: 2020 Versus 2024 Versus 2031
  • 1.3.2 Global Antibody Development and Production Services Consumption Value Market Share by Type in 2024
  • 1.3.3 Antibody Production
  • 1.3.4 Antibody Conjugation
  • 1.3.5 Antibody Purification
  • 1.3.6 Hybridoma Development
  • 1.3.7 Antibody Design
  • 1.3.8 Antibody Humanization
  • 1.3.9 Others
• 1.4 Global Antibody Development and Production Services Market by Application
  • 1.4.1 Overview: Global Antibody Development and Production Services Market Size by Application: 2020 Versus 2024 Versus 2031
  • 1.4.2 Biopharma
  • 1.4.3 Diagnostics
  • 1.4.4 Emerging Therapeutics
  • 1.4.5 Others
• 1.5 Global Antibody Development and Production Services Market Size & Forecast
• 1.6 Global Antibody Development and Production Services Market Size and Forecast by Region
  • 1.6.1 Global Antibody Development and Production Services Market Size by Region: 2020 VS 2024 VS 2031
  • 1.6.2 Global Antibody Development and Production Services Market Size by Region, (2020-2031)
  • 1.6.3 North America Antibody Development and Production Services Market Size and Prospect (2020-2031)
  • 1.6.4 Europe Antibody Development and Production Services Market Size and Prospect (2020-2031)
  • 1.6.5 Asia-Pacific Antibody Development and Production Services Market Size and Prospect (2020-2031)
  • 1.6.6 South America Antibody Development and Production Services Market Size and Prospect (2020-2031)
  • 1.6.7 Middle East & Africa Antibody Development and Production Services Market Size and Prospect (2020-2031)

2 Company Profiles

• 2.1 Abcam
  • 2.1.1 Abcam Details
  • 2.1.2 Abcam Major Business
  • 2.1.3 Abcam Antibody Development and Production Services Product and Solutions
  • 2.1.4 Abcam Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.1.5 Abcam Recent Developments and Future Plans
• 2.2 GenScript
  • 2.2.1 GenScript Details
  • 2.2.2 GenScript Major Business
  • 2.2.3 GenScript Antibody Development and Production Services Product and Solutions
  • 2.2.4 GenScript Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.2.5 GenScript Recent Developments and Future Plans
• 2.3 Biointron
  • 2.3.1 Biointron Details
  • 2.3.2 Biointron Major Business
  • 2.3.3 Biointron Antibody Development and Production Services Product and Solutions
  • 2.3.4 Biointron Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.3.5 Biointron Recent Developments and Future Plans
• 2.4 Sino Biological
  • 2.4.1 Sino Biological Details
  • 2.4.2 Sino Biological Major Business
  • 2.4.3 Sino Biological Antibody Development and Production Services Product and Solutions
  • 2.4.4 Sino Biological Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.4.5 Sino Biological Recent Developments and Future Plans
• 2.5 R&D Systems
  • 2.5.1 R&D Systems Details
  • 2.5.2 R&D Systems Major Business
  • 2.5.3 R&D Systems Antibody Development and Production Services Product and Solutions
  • 2.5.4 R&D Systems Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.5.5 R&D Systems Recent Developments and Future Plans
• 2.6 WuXi Biologics
  • 2.6.1 WuXi Biologics Details
  • 2.6.2 WuXi Biologics Major Business
  • 2.6.3 WuXi Biologics Antibody Development and Production Services Product and Solutions
  • 2.6.4 WuXi Biologics Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.6.5 WuXi Biologics Recent Developments and Future Plans
• 2.7 Antibodies
  • 2.7.1 Antibodies Details
  • 2.7.2 Antibodies Major Business
  • 2.7.3 Antibodies Antibody Development and Production Services Product and Solutions
  • 2.7.4 Antibodies Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.7.5 Antibodies Recent Developments and Future Plans
• 2.8 ProteoGenix
  • 2.8.1 ProteoGenix Details
  • 2.8.2 ProteoGenix Major Business
  • 2.8.3 ProteoGenix Antibody Development and Production Services Product and Solutions
  • 2.8.4 ProteoGenix Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.8.5 ProteoGenix Recent Developments and Future Plans
• 2.9 ARVYS Proteins
  • 2.9.1 ARVYS Proteins Details
  • 2.9.2 ARVYS Proteins Major Business
  • 2.9.3 ARVYS Proteins Antibody Development and Production Services Product and Solutions
  • 2.9.4 ARVYS Proteins Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.9.5 ARVYS Proteins Recent Developments and Future Plans
• 2.10 Envigo
  • 2.10.1 Envigo Details
  • 2.10.2 Envigo Major Business
  • 2.10.3 Envigo Antibody Development and Production Services Product and Solutions
  • 2.10.4 Envigo Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.10.5 Envigo Recent Developments and Future Plans
• 2.11 ProMab
  • 2.11.1 ProMab Details
  • 2.11.2 ProMab Major Business
  • 2.11.3 ProMab Antibody Development and Production Services Product and Solutions
  • 2.11.4 ProMab Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.11.5 ProMab Recent Developments and Future Plans
• 2.12 Thermo Fisher Scientific
  • 2.12.1 Thermo Fisher Scientific Details
  • 2.12.2 Thermo Fisher Scientific Major Business
  • 2.12.3 Thermo Fisher Scientific Antibody Development and Production Services Product and Solutions
  • 2.12.4 Thermo Fisher Scientific Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.12.5 Thermo Fisher Scientific Recent Developments and Future Plans
• 2.13 OriGene
  • 2.13.1 OriGene Details
  • 2.13.2 OriGene Major Business
  • 2.13.3 OriGene Antibody Development and Production Services Product and Solutions
  • 2.13.4 OriGene Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.13.5 OriGene Recent Developments and Future Plans
• 2.14 Creative Biolabs
  • 2.14.1 Creative Biolabs Details
  • 2.14.2 Creative Biolabs Major Business
  • 2.14.3 Creative Biolabs Antibody Development and Production Services Product and Solutions
  • 2.14.4 Creative Biolabs Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.14.5 Creative Biolabs Recent Developments and Future Plans
• 2.15 Rockland
  • 2.15.1 Rockland Details
  • 2.15.2 Rockland Major Business
  • 2.15.3 Rockland Antibody Development and Production Services Product and Solutions
  • 2.15.4 Rockland Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.15.5 Rockland Recent Developments and Future Plans
• 2.16 BBI Solutions
  • 2.16.1 BBI Solutions Details
  • 2.16.2 BBI Solutions Major Business
  • 2.16.3 BBI Solutions Antibody Development and Production Services Product and Solutions
  • 2.16.4 BBI Solutions Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.16.5 BBI Solutions Recent Developments and Future Plans
• 2.17 BioGenes
  • 2.17.1 BioGenes Details
  • 2.17.2 BioGenes Major Business
  • 2.17.3 BioGenes Antibody Development and Production Services Product and Solutions
  • 2.17.4 BioGenes Antibody Development and Production Services Revenue, Gross Margin and Market Share (2020-2025)
  • 2.17.5 BioGenes Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Antibody Development and Production Services Revenue and Share by Players (2020-2025)
• 3.2 Market Share Analysis (2024)
  • 3.2.1 Market Share of Antibody Development and Production Services by Company Revenue
  • 3.2.2 Top 3 Antibody Development and Production Services Players Market Share in 2024
  • 3.2.3 Top 6 Antibody Development and Production Services Players Market Share in 2024
• 3.3 Antibody Development and Production Services Market: Overall Company Footprint Analysis
  • 3.3.1 Antibody Development and Production Services Market: Region Footprint
  • 3.3.2 Antibody Development and Production Services Market: Company Product Type Footprint
  • 3.3.3 Antibody Development and Production Services Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Antibody Development and Production Services Consumption Value and Market Share by Type (2020-2025)
• 4.2 Global Antibody Development and Production Services Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

• 5.1 Global Antibody Development and Production Services Consumption Value Market Share by Application (2020-2025)
• 5.2 Global Antibody Development and Production Services Market Forecast by Application (2026-2031)

6 North America

• 6.1 North America Antibody Development and Production Services Consumption Value by Type (2020-2031)
• 6.2 North America Antibody Development and Production Services Market Size by Application (2020-2031)
• 6.3 North America Antibody Development and Production Services Market Size by Country
  • 6.3.1 North America Antibody Development and Production Services Consumption Value by Country (2020-2031)
  • 6.3.2 United States Antibody Development and Production Services Market Size and Forecast (2020-2031)
  • 6.3.3 Canada Antibody Development and Production Services Market Size and Forecast (2020-2031)
  • 6.3.4 Mexico Antibody Development and Production Services Market Size and Forecast (2020-2031)

7 Europe

• 7.1 Europe Antibody Development and Production Services Consumption Value by Type (2020-2031)
• 7.2 Europe Antibody Development and Production Services Consumption Value by Application (2020-2031)
• 7.3 Europe Antibody Development and Production Services Market Size by Country
  • 7.3.1 Europe Antibody Development and Production Services Consumption Value by Country (2020-2031)
  • 7.3.2 Germany Antibody Development and Production Services Market Size and Forecast (2020-2031)
  • 7.3.3 France Antibody Development and Production Services Market Size and Forecast (2020-2031)
  • 7.3.4 United Kingdom Antibody Development and Production Services Market Size and Forecast (2020-2031)
  • 7.3.5 Russia Antibody Development and Production Services Market Size and Forecast (2020-2031)
  • 7.3.6 Italy Antibody Development and Production Services Market Size and Forecast (2020-2031)

8 Asia-Pacific

• 8.1 Asia-Pacific Antibody Development and Production Services Consumption Value by Type (2020-2031)
• 8.2 Asia-Pacific Antibody Development and Production Services Consumption Value by Application (2020-2031)
• 8.3 Asia-Pacific Antibody Development and Production Services Market Size by Region
  • 8.3.1 Asia-Pacific Antibody Development and Production Services Consumption Value by Region (2020-2031)
  • 8.3.2 China Antibody Development and Production Services Market Size and Forecast (2020-2031)
  • 8.3.3 Japan Antibody Development and Production Services Market Size and Forecast (2020-2031)
  • 8.3.4 South Korea Antibody Development and Production Services Market Size and Forecast (2020-2031)
  • 8.3.5 India Antibody Development and Production Services Market Size and Forecast (2020-2031)
  • 8.3.6 Southeast Asia Antibody Development and Production Services Market Size and Forecast (2020-2031)
  • 8.3.7 Australia Antibody Development and Production Services Market Size and Forecast (2020-2031)

9 South America

• 9.1 South America Antibody Development and Production Services Consumption Value by Type (2020-2031)
• 9.2 South America Antibody Development and Production Services Consumption Value by Application (2020-2031)
• 9.3 South America Antibody Development and Production Services Market Size by Country
  • 9.3.1 South America Antibody Development and Production Services Consumption Value by Country (2020-2031)
  • 9.3.2 Brazil Antibody Development and Production Services Market Size and Forecast (2020-2031)
  • 9.3.3 Argentina Antibody Development and Production Services Market Size and Forecast (2020-2031)

10 Middle East & Africa

• 10.1 Middle East & Africa Antibody Development and Production Services Consumption Value by Type (2020-2031)
• 10.2 Middle East & Africa Antibody Development and Production Services Consumption Value by Application (2020-2031)
• 10.3 Middle East & Africa Antibody Development and Production Services Market Size by Country
  • 10.3.1 Middle East & Africa Antibody Development and Production Services Consumption Value by Country (2020-2031)
  • 10.3.2 Turkey Antibody Development and Production Services Market Size and Forecast (2020-2031)
  • 10.3.3 Saudi Arabia Antibody Development and Production Services Market Size and Forecast (2020-2031)
  • 10.3.4 UAE Antibody Development and Production Services Market Size and Forecast (2020-2031)

11 Market Dynamics

• 11.1 Antibody Development and Production Services Market Drivers
• 11.2 Antibody Development and Production Services Market Restraints
• 11.3 Antibody Development and Production Services Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

• 12.1 Antibody Development and Production Services Industry Chain
• 12.2 Antibody Development and Production Services Upstream Analysis
• 12.3 Antibody Development and Production Services Midstream Analysis
• 12.4 Antibody Development and Production Services Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global Antibody Development and Production Services market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Antibody Development and Production Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antibody Development and Production Services market size and forecasts, in consumption value ($ Million), 2020-2031
Global Antibody Development and Production Services market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Antibody Development and Production Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Antibody Development and Production Services market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody Development and Production Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody Development and Production Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abcam, GenScript, Biointron, Sino Biological, R&D Systems, WuXi Biologics, Antibodies, ProteoGenix, ARVYS Proteins, Envigo, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Antibody Development and Production Services market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Antibody Production
Antibody Conjugation
Antibody Purification
Hybridoma Development
Antibody Design
Antibody Humanization
Others
Market segment by Application
Biopharma
Diagnostics
Emerging Therapeutics
Others
Market segment by players, this report covers
Abcam
GenScript
Biointron
Sino Biological
R&D Systems
WuXi Biologics
Antibodies
ProteoGenix
ARVYS Proteins
Envigo
ProMab
Thermo Fisher Scientific
OriGene
Creative Biolabs
Rockland
BBI Solutions
BioGenes
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antibody Development and Production Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibody Development and Production Services, with revenue, gross margin, and global market share of Antibody Development and Production Services from 2020 to 2025.
Chapter 3, the Antibody Development and Production Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Antibody Development and Production Services market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Development and Production Services.
Chapter 13, to describe Antibody Development and Production Services research findings and conclusion.